Liposomes as an ocular delivery system for acetazolamide: In vitro and in vivo studies
- 1 March 2007
- journal article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 8 (1) , E1-E12
Abstract
The purpose of this study was to formulate topically effective controlled release ophthalmic acetazolamide liposomal formulations. Reverse-phase evaporatioKeywords
This publication has 33 references indexed in Scilit:
- Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamideInternational Journal of Pharmaceutics, 2005
- Vesicular systems in ocular drug delivery: an overviewInternational Journal of Pharmaceutics, 2004
- Acetazolamide: future perspective in topical glaucoma therapeuticsInternational Journal of Pharmaceutics, 2002
- Ocular Preparations: The Formulation ApproachDrug Development and Industrial Pharmacy, 2002
- Formulation and evaluation of ophthalmic preparations of acetazolamideInternational Journal of Pharmaceutics, 2000
- Preparation and evaluation of acetazolamide liposomes as an ocular delivery systemInternational Journal of Pharmaceutics, 1997
- Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbitsJournal of Pharmacy and Pharmacology, 1994
- N-Substituted sulfonamide carbonic anhydrase inhibitors with topical effects on intraocular pressureJournal of Medicinal Chemistry, 1986
- The in vitro release of steroids from liposomesInternational Journal of Pharmaceutics, 1983
- Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation.Proceedings of the National Academy of Sciences, 1978